Literature DB >> 21109294

Contemporary lymph node counts during primary retroperitoneal lymph node dissection.

R Houston Thompson1, Brett S Carver, George J Bosl, Dean Bajorin, Robert Motzer, Darren R Feldman, Victor E Reuter, Joel Sheinfeld.   

Abstract

OBJECTIVES: Recent observations suggest that surgeon volume is associated with lymph node counts during retroperitoneal lymph node dissection (RPLND). We report our contemporary single-surgeon experience with lymph node counts during primary RPLND for nonseminomatous germ cell tumors.
METHODS: Using the Memorial Sloan-Kettering Cancer Center Testis Cancer Registry, we identified 124 consecutive patients treated with primary RPLND by a single experienced surgeon for nonseminomatous germ cell tumors between 2004 and 2008. Predictors of positive nodes and number of positive nodes were evaluated with logistic and linear regression models adjusting for year of surgery and clinical stage.
RESULTS: Positive lymph nodes were observed in 37 patients (30%), whereas 87 patients (70%) were pN0. Mean total node count was 51 (standard deviation [SD] = 23) during the 5-year study period. Mean node counts for the paracaval, interaortocaval, and paraaortic regions were 8 (SD = 6), 17 (SD = 9), and 26 (SD = 15), respectively. In a multivariate analysis, higher total node count was significantly associated with finding positive nodes (odds ratio = 1.02 for each additional node counted; P = .037) and finding multiple positive nodes (linear regression coefficient = 0.04 for each additional node counted; P = .004). Year of surgery (P < .001) was associated with higher total node counts, whereas clinical stage and pathologist were not (P > .5 for each).
CONCLUSIONS: The average total node count for a primary RPLND by an experienced surgeon is approximately 50 nodes, with nearly half of the nodes originating in the paraaortic region. These results will be useful when assessing the adequacy of lymph node dissections for testis, renal, and upper tract urothelial malignancies.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21109294      PMCID: PMC4012337          DOI: 10.1016/j.urology.2010.05.020

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  28 in total

Review 1.  Prognostic value of nodal ratios in node-positive breast cancer.

Authors:  Wendy A Woodward; Vincent Vinh-Hung; Naoto T Ueno; Yee Chung Cheng; Melanie Royce; Patricia Tai; Georges Vlastos; Anne Marie Wallace; Gabriel N Hortobagyi; Yago Nieto
Journal:  J Clin Oncol       Date:  2006-06-20       Impact factor: 44.544

2.  Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion.

Authors:  Andrew J Stephenson; George J Bosl; Dean F Bajorin; Jason Stasi; Robert J Motzer; Joel Sheinfeld
Journal:  J Urol       Date:  2005-08       Impact factor: 7.450

3.  Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome.

Authors:  Andrew J Stephenson; George J Bosl; Robert J Motzer; Michael W Kattan; Jason Stasi; Dean F Bajorin; Joel Sheinfeld
Journal:  J Clin Oncol       Date:  2005-04-20       Impact factor: 44.544

4.  Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors?

Authors:  Elfriede Bollschweiler; Stephan E Baldus; Wolfgang Schröder; Paul M Schneider; Arnulf H Hölscher
Journal:  J Surg Oncol       Date:  2006-10-01       Impact factor: 3.454

5.  Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database.

Authors:  David D Smith; Rebecca R Schwarz; Roderich E Schwarz
Journal:  J Clin Oncol       Date:  2005-10-01       Impact factor: 44.544

6.  Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer.

Authors:  Michelle S Ludwig; Michael Goodman; Daniel L Miller; Peter A S Johnstone
Journal:  Chest       Date:  2005-09       Impact factor: 9.410

7.  Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database.

Authors:  Roderich E Schwarz; David D Smith
Journal:  Ann Surg Oncol       Date:  2006-09-06       Impact factor: 5.344

8.  Evaluation of lymph node counts in primary retroperitoneal lymph node dissection.

Authors:  R Houston Thompson; Brett S Carver; George J Bosl; Dean Bajorin; Robert Motzer; Darren Feldman; Victor E Reuter; Joel Sheinfeld
Journal:  Cancer       Date:  2010-11-15       Impact factor: 6.860

9.  Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: clinical presentation, patterns of recurrence, and outcome.

Authors:  James M McKiernan; Robert J Motzer; Dean F Bajorin; Jennifer Bacik; George J Bosl; Joel Sheinfeld
Journal:  Urology       Date:  2003-10       Impact factor: 2.649

10.  Late relapse of testicular cancer.

Authors:  J Baniel; R S Foster; R Gonin; J E Messemer; J P Donohue; L H Einhorn
Journal:  J Clin Oncol       Date:  1995-05       Impact factor: 44.544

View more
  2 in total

Review 1.  Postchemotherapy surgery for germ cell tumors--what have we learned in 35 years?

Authors:  Stephen B Riggs; Earl F Burgess; Kris E Gaston; Caroline A Merwarth; Derek Raghavan
Journal:  Oncologist       Date:  2014-04-09

2.  Body mass index is associated with higher lymph node counts during retroperitoneal lymph node dissection.

Authors:  R Houston Thompson; Brett S Carver; George J Bosl; Dean Bajorin; Robert Motzer; Darren Feldman; Victor E Reuter; Joel Sheinfeld
Journal:  Urology       Date:  2011-12-14       Impact factor: 2.649

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.